Latest

• Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
• The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
• Chromosome 3p Microsatellite Allelotyping in Neuroblastoma: A Report on the Technical Hurdles
• Aberrant methylation of candidate tumor suppressor genes in neuroblastoma
• CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
• High throughput analyses for assessment of DNA copy number and methylation status for chromosome 3p genes in high-risk neuroblastoma